Avai Bio (AVAI) Short term Debt (2018 - 2023)

Avai Bio has disclosed Short term Debt across 6 years of filings, most recently posting $99000.0 for Q3 2023.

• Short term Debt for Q3 2023 came in at $99000.0, down 47.09% year-over-year; the trailing twelve-month figure through Sep 2023 was $99000.0 (down 47.09% YoY), and the FY2023 annual result was $99000.0, changed 0.0% from the prior year.
• Short term Debt came in at $99000.0 for Q3 2023 at Avai Bio, roughly flat from $99000.0 in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $216668.0 in Q4 2022 to a low of $5056.0 in Q2 2022.
• The 5-year median for Short term Debt is $99000.0 (2022), against an average of $84480.9.
• Across the five-year window, Short term Debt plunged 96.46% in 2020 and surged 2638.67% in 2022, its largest moves.
• Avai Bio's Short term Debt stood at $195345.0 in 2019, then plunged by 85.08% to $29141.0 in 2020, then surged by 387.57% to $142082.0 in 2021, then surged by 52.5% to $216668.0 in 2022, then sank by 54.31% to $99000.0 in 2023.
• The last three Short term Debt figures came in at $99000.0 (Q3 2023), $99000.0 (Q2 2023), and $99000.0 (Q1 2023), per Business Quant data.